ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,259Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 973

$840K Total Retail Price of All Prescriptions

Rank: 21 out of 973

447 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 447 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 11,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 611 489 1 2
HYDROCODONE-ACETAMINOPHEN 557 348 S3 2 4
SIMVASTATIN 429 341 3 1
AMLODIPINE BESYLATE 405 362 4 7
OMEPRAZOLE 394 286 5 5
FUROSEMIDE 326 278 6 6
PRAVASTATIN SODIUM 312 275 7 22
METOPROLOL TARTRATE 293 229 8 13
GABAPENTIN 250 151 9 12
METFORMIN HCL 233 167 10 8
SERTRALINE HCL 215 177 11 21
LISINOPRIL 212 163 12 3
FLUOXETINE HCL 197 154 13 56
METOPROLOL SUCCINATE 186 163 14 17
DIGOXIN 178 178 15 32
CYMBALTA 178 110 15 40
RISPERIDONE 170 141 17 65
POTASSIUM CHLORIDE 170 139 17 9
TRAMADOL HCL 168 124 19 18
WARFARIN SODIUM 157 126 20 10
EXELON 155 155 21 117
NAMENDA 149 149 22 31
ATORVASTATIN CALCIUM 142 110 23 15
GLIMEPIRIDE 139 116 24 41
TAMSULOSIN HCL 138 109 25 28
AMITRIPTYLINE HCL 131 87 R 26 52
ZOLPIDEM TARTRATE 129 73 27 20
ALLOPURINOL 126 105 28 29
ENABLEX 124 112 29 174
PREMARIN 122 81 R 30 116
DONEPEZIL HCL 120 119 31 26
SYNTHROID 118 118 32 50
LOSARTAN POTASSIUM 114 110 33 19
CITALOPRAM HBR 113 100 34 14
NEXIUM 111 71 35 30
TRIAMTERENE-HCTZ 111 86 35 51
POLYETHYLENE GLYCOL 3350 111 107 35 36
SPIRONOLACTONE 111 79 35 49
ATENOLOL 110 79 39 16
HYDROCHLOROTHIAZIDE 99 99 40 11
DIOVAN 97 77 41 63
CRESTOR 96 76 42 34
ROPINIROLE HCL 95 70 43 72
LOVASTATIN 93 61 44 38
ZETIA 90 71 45 81
AZITHROMYCIN 90 72 45 47
FENTANYL 90 66 S2 45 53
MIRTAZAPINE 87 86 48 43
METOCLOPRAMIDE HCL 84 59 49 93
CEPHALEXIN 83 65 50 75
AMLODIPINE BESYLATE-BENAZEPRIL 82 70 51 80
QUETIAPINE FUMARATE 80 38 52 70
JANUVIA 79 58 53 88
PANTOPRAZOLE SODIUM 77 72 54 37
NOVOLOG 75 50 55 82
LOSARTAN-HYDROCHLOROTHIAZIDE 75 50 55 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 56 57 25
ACTOS 73 40 57 119
CARBIDOPA-LEVODOPA 72 56 59 71
TRIAMCINOLONE ACETONIDE 71 71 60 120
CYCLOBENZAPRINE HCL 70 12 R 61 42
LANTUS 69 41 62 39
TRICOR 66 28 63 143
MELOXICAM 65 36 64 23
OXYBUTYNIN CHLORIDE ER 64 42 65 125
EVISTA 63 59 66 121
ESCITALOPRAM OXALATE 63 35 66 68
FAMOTIDINE 62 30 68 61
CARVEDILOL 61 47 69 27
DILTIAZEM ER 61 52 69 109
ALENDRONATE SODIUM 59 49 71 24
CHLORTHALIDONE 58 38 72 156
HYDROXYZINE HCL 58 45 R 72 190
TRAZODONE HCL 57 21 74 48
METFORMIN HCL ER 56 39 75 58
DOXYCYCLINE HYCLATE 55 37 76 96
VERAPAMIL ER 54 42 77 111
CIPROFLOXACIN HCL 53 49 78 57
ACETAMINOPHEN-CODEINE 52 45 S3 79 134
OXYCODONE-ACETAMINOPHEN 52 33 S2 79 89
LIPITOR 51 45 81 139
VENLAFAXINE HCL ER 51 45 81 95
LEVOTHROID 50 50 83 228
ADVAIR DISKUS 50 40 83 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.